EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Trh suppressed gastric acid output in patients with zollinger ellison syndrome and systemic mastocytosis






American Journal of Medicine 71(6): 957-960

Trh suppressed gastric acid output in patients with zollinger ellison syndrome and systemic mastocytosis

TRH administered i.v. was as potent an inhibitor of gastric acid secretion as a conventional dose of oral cimetidine in 2 patients with Zollinger-Ellison syndrome and 1 patient with systemic mastocytosis.

(PDF 0-2 workdays service: $29.90)

Accession: 006839816



Related references

Thyrotropin-releasing hormone suppressed gastric acid output in patients with Zollinger-Ellison syndrome and systemic mastocytosis. American Journal of Medicine 71(6): 957-960, 1981

Parenteral control of gastric acid output in patients with zollinger ellison syndrome zes. Gastroenterology 100(5 PART 2): A79, 1991

Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. American Journal of Gastroenterology 102(12): 2648-2654, 2007

Thyrotropin releasing hormone suppress gastric acid output in patients with zollinger ellison syndrome. Clinical Research 28(4): 724A, 1980

Effect of somatostatin on serum gastrin levels and on gastric acid output in patients with zollinger ellison syndrome. Scandinavian Journal of Gastroenterology Supplement 18(82): 205-206, 1982

Effects of lansoprazole and omeprazole on 24 hour gastric acidity and baseline acid output in nine patients with Zollinger-Ellison syndrome. Gastroenterologie Clinique et Biologique 18(8-9): 695-701, 1994

Does the magnitude of gastric acid output correlate with the extent of hypergastrinemia in patients with zollinger-ellison syndrome ? A prospective study. Gastroenterology 116(4 PART 2): A170-A171, April, 1999

Effects of pantoprazole versus reference PPIs on 24-hour gastric acidity and basal acid output in patients with Zollinger-Ellison Syndrome. Gastroenterology 116(4 PART 2): A252, April, 1999

Systemic mastocytosis and the Zollinger-Ellison syndrome. Schweizerische Rundschau für Medizin Praxis 63(18): 558-559, 1974

Intravenous pantoprazole rapidly and effectively controls acid output in patients with Zollinger-Ellison Syndrome. Gastroenterology 114(4 PART 2): A226, April 15, 1998